VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 36 filers reported holding VINCERX PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Citadel Advisors | 168,829 | $173,893 | 0.00% |
| Qube Research & Technologies Ltd | 4 | $4 | 0.00% |
| Walleye Capital LLC | 115,044 | $118,495 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,452,907 | $1,467,436 | 0.00% |
| Renaissance Technologies | 132,900 | $134 | 0.00% |
| BARCLAYS PLC | 2,556 | $3 | 0.00% |
| VANGUARD GROUP INC | 513,420 | $518,555 | 0.00% |
| LMR Partners LLP | 10,000 | $10,100 | 0.00% |
| UBS Group AG | 5,736 | $5,793 | 0.00% |
| WADE G W & INC | 10,900 | $11 | 0.00% |
| FMR LLC | 6 | $6 | 0.00% |
| Tower Research Capital LLC (TRC) | 7,178 | $7,250 | 0.00% |
| WELLS FARGO & COMPANY/MN | 126 | $127 | 0.00% |
| NORTHERN TRUST CORP | 25,614 | $25,870 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 154,031 | $158,714 | 0.00% |
External links
This page lists VINCERX PHARMA INC's shareholders in Q3 2023. To view VINCERX PHARMA INC's shareholder history, click here.